Piramal Pharma Limited (NSE:PPLPHARMA)
India · Delayed Price · Currency is INR 211.18
-5.70 (-2.63%)
Jul 18, 2025, 3:30 PM IST
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 280.71 billion as of July 18, 2025. Its market cap has increased by 31.64% in one year.
Market Cap
280.71B
Enterprise Value
324.07B
Revenue
91.51B
Ranking
n/a
PE Ratio
308.03
Stock Price
211.18
Market Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has increased from 226.73B to 280.71B, an increase of 23.81%. That is a compound annual growth rate of 8.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 18, 2025 | 280.71B | -20.47% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,063.51B |
| Divi's Laboratories | 1,787.00B |
| Cipla | 1,197.33B |
| Mankind Pharma | 1,094.68B |
| Apollo Hospitals Enterprise | 1,050.13B |
| Zydus Lifesciences | 981.03B |
| Aurobindo Pharma | 661.82B |
| Glenmark Pharmaceuticals | 628.04B |